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Abstract
Background: We aimed to investigate the extent of the agreement on practices around brain death and postmortem
organ donation.
Methods: Investigators from 67 Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury
(CENTER-TBI) study centers completed several questionnaires (response rate: 99%).
Results: Regarding practices around brain death, we found agreement on the clinical evaluation (prerequisites and
neurological assessment) for brain death determination (BDD) in 100% of the centers. However, ancillary tests were
required for BDD in 64% of the centers. BDD for nondonor patients was deemed mandatory in 18% of the centers
before withdrawing life-sustaining measures (LSM). Also, practices around postmortem organ donation varied. Organ
donation after circulatory arrest was forbidden in 45% of the centers. When withdrawal of LSM was contemplated, in
67% of centers the patients with a ventricular drain in situ had this removed, either sometimes or all of the time.
Conclusions: This study showed both agreement and some regional differences regarding practices around brain
death and postmortem organ donation. We hope our results help quantify and understand potential differences, and
provide impetus for current dialogs toward further harmonization of practices around brain death and postmortem
organ donation.
Keywords: Traumatic brain injury, Brain death, Ethics, Postmortem organ donation, Withdrawing life-sustaining
measures, Ventricular drainage
Background
Before the 1950s, death was only determined using
cardiovascular criteria. Due to advances in critical care
medicine, especially mechanical ventilation, a new
clinical state was observed in 1958 (i.e., “coma dépassé”)
[1]. Although the systemic circulation was intact, the
brain showed no objective evidence of function. This
observation gave rise to the question of what “coma
dépassé” meant. The successful transplantation of kid-
neys from a “coma dépassé” patient (1965) subsequently
led to the first accepted standard for the confirmation of
brain death in 1968 [2]. In 1981, the Uniform Determin-
ation of Death Act made death determined by neuro-
logical and cardiovascular criteria equivalent [3]. The
American Academy of Neurology (AAN) in 1995 pub-
lished guidelines for brain death determination (BDD)
[4], and updated these in 2010 [5]. In 2008, the Academy
of Medical Royal Colleges in the United Kingdom (UK)
provided broader guidance on the determination of
death in a range of circumstances, including BDD [6].
Brain death and postmortem organ donation are closely
linked. Also, an important, and not well investigated, issue
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regarding circulatory arrest organ donation is the
hands-off time after circulatory arrest. Practices around all
of these mentioned topics are delicate. Thus, inconsisten-
cies between centers can be confusing for the general
public, and could expose clinicians to accusations of
unethical practice. Consensus regarding practices around
brain death and postmortem organ donation could
prevent these inconsistencies. To facilitate this consensus,
the first step is to document potential differences.
The Collaborative European NeuroTrauma Effective-
ness Research in Traumatic Brain Injury (CENTER-TBI,
www.center-tbi.eu) study addressed this issue. The
CENTER-TBI study used questionnaires to create “pro-
vider profiles” of participating neurotrauma centers. One
of these questionnaires intended to address specific
practices around brain death and postmortem organ
donation that currently provoke international discussion.
Using this questionnaire, we aimed to quantify and
understand potential differences, and provide impetus
for current dialogs toward further harmonization of prac-
tices around brain death and postmortem organ donation.
Regarding brain death, we investigated: criteria used for
BDD; and the necessity of BDD before withdrawing
life-sustaining measures (LSM). As for postmortem organ
donation, we investigated: removal of the ventricular drain
while continuing other LSM; the possibility for circulatory
arrest organ donation; and the hands-off time after
circulatory arrest.
Methods
CENTER-TBI and study sample
The CENTER-TBI study includes a prospective observa-
tional study on traumatic brain injury (TBI) [7, 8]. The
investigators connected to this study collect data on pa-
tient characteristics, management, and outcomes in im-
portant centers from 20 countries across Europe and
Israel. Investigators from all participating centers in the
CENTER-TBI study were asked to complete several
questionnaires. Centers were located in Austria (N = 2),
Belgium (N = 4), Bosnia and Herzegovina (N = 2),
Denmark (N = 2), Finland (N = 2), France (N = 7),
Germany (N = 4), Hungary (N = 2), Israel (N = 2), Italy
(N = 8), Latvia (N = 3), Lithuania (N = 2), the Netherlands
(N = 7), Norway (N = 3), Romania (N = 1), Serbia (N = 1),
Spain (N = 4), Sweden (N = 2), Switzerland (N = 1), and
the UK (N = 8).
Questionnaire development and administration
More detailed information about the development, ad-
ministration, and content of the questionnaires is avail-
able from an earlier publication by Cnossen et al. [9].
The topics covered in the current study are summa-
rized in Table 1. A complete overview of the question-
naires for this study can be found in Additional file 1:
Questionnaire 1 (questions 1, 4, 8, and 9), 7 (questions 2
and 4), and 8 (questions 9 and 11–15). In the question-
naires, we explicitly asked for the “general policy” ac-
cording to the investigators. We defined this as the local
standards used in more than 75% of patients, recogniz-
ing that there might be exceptions. Most questions made
use of categorical answer categories. For some questions,
the investigators had the option to fill in an answer that
could be different from one of the options provided.
These answers were marked as “other” and consisted of
free text responses. Where these free text responses
from different investigators were sufficiently similar, we
sought to combine them to provide additional
categorical responses. We did this to facilitate summary
descriptive statistics.
Analyses
We used descriptive statistics to describe our outcomes.
We calculated frequencies and percentages for all
variables related to the number of responses for that
question. Centers at which the investigator did not
respond to every question remained in our study, in
order to keep groups for descriptive statistics as large as
possible. The response rates per question are presented
in Table 1. We grouped countries into seven regions:
Baltic States (Latvia and Lithuania), Eastern Europe
(Bosnia and Herzegovina, Hungary, Romania, and
Serbia), Israel, Northern Europe (Denmark, Finland,
Norway, and Sweden), Southern Europe (Italy and
Spain), the United Kingdom, and Western Europe
(Austria, Belgium, France, Germany, the Netherlands,
and Switzerland). We examined potential differences
between and within regions.
Results
Center characteristics
Of the 68 centers, investigators from 67 centers participated
in the questionnaires (response rate: 99%) and were in-
cluded in the analysis. The participating centers were
mainly academic centers (N = 61, 91%), designated as a
level I or II trauma center (N = 49, 73%). The average num-
ber of beds in the participating centers was 1187, of which
on average 39 were intensive care unit (ICU) beds. The
average number of annual treatments per ICU in 2013 was
1408, of which on average 130 were TBI patients.
Practices around brain death
When do you declare a patient brain dead?
We found agreement on the clinical evaluation (prerequi-
sites and neurological assessment) for BDD in 100% of the
centers. The clinical evaluation for BDD included: a
Glasgow Coma Scale (GCS) of three, absence of brain
stem reflexes, no respiratory efforts in response to an
apnea test, and absence of confounding factors to
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evaluate consciousness (e.g., hypothermia). However,
ancillary tests were required for BDD in 43 (64%)
centers (Table 2).
In three regions (43%; Israel, Southern Europe, and the
UK), the same criteria for BDD were used in every cen-
ter of the same region. In centers from Northern Europe
and the UK, ancillary tests were rarely used for BDD (N
= 2, 22% and N = 0, 0%, respectively).
Must the patient, who is not suitable for organ donation,
be declared brain dead before withdrawing LSM?
The declaration of brain death in nondonor patients was
mandatory before withdrawing LSM in 12 (18%) centers. In
41 (61%) centers, a poor prognosis as assessed by the treat-
ing physician(s) was considered sufficient. In 9 (13%) cen-
ters, a GCS score of three, fixed dilated pupils, and absence
of confounders could motivate withdrawing LSM (Table 2).
Table 1 Topics covered, related questions for each topic, and response rate per question
Topics covered in this study Questions related to this topic Response rate,
N (%)
Practices around brain death
Criteria for BDD When do you declare a patient brain dead? 67 (99%)
Brain death and withdrawal of LSM Must the patient, who is not suitable for organ donation, be declared
brain dead before withdrawing life-sustaining measures?
67 (99%)
Practices around postmortem organ donation
Donation after circulatory death Would you consider organ donation after circulatory arrest in a
patient in whom mechanical ventilation will be withdrawn, but who
is not brain dead?
66 (97%)
Ventricular drain removal and organ donation If the decision is made to withdraw life-sustaining measures, in a pa-
tient with high intracranial pressure, but who is not brain dead,
would you remove the ventricular drain (for CSF drainage), but con-
tinue other life-sustaining measures in the hope that the patient will
become brain dead and thereby becomes a suitable candidate for
organ donation?
67 (99%)
Declaration of death and hands-off time in
donors and nondonors
After withdrawal of mechanical ventilation and after circulatory arrest,
when exactly do you declare the patient dead in case of a circulatory
death organ donor?
64 (94%)
After withdrawal of mechanical ventilation and after circulatory arrest,
after how many minutes circulatory arrest do you declare the patient
dead in cases not suitable as organ donor?
66 (97%)
BDD brain death determination, CSF cerebrospinal fluid, LSM life-sustaining measures
Table 2 Practices around brain death
Region
Answer Sample
total
(N = 67)
Baltic
States
(N = 5)
Eastern
Europe
(N = 6)
Israel
(N =
2)
Northern
Europe
(N = 9)
Southern
Europe
(N = 12)
United
Kingdom
(N = 8)
Western
Europe
(N = 25)
When do you declare a patient brain dead?
With GCS 3, fixed dilated pupils, and no confounding factors
(e.g., hypothermia, barbiturates)
0 0 0 0 0 0 0 0
With GCS 3 and absent brain stem reflexes, and no
confounding factors
0 0 0 0 0 0 0 0
With GCS 3, absent brain stem reflexes and apnea, and no
confounding factors
31 20 17 0 78 0 88 20
With GCS 3, absent brain stem reflexes, apnea and ancillary
test(s) (e.g., EEG or cerebral angiography), and absence of
confounding factors
64 80 83 100 22 100 0 72
Per national protocola 4 0 0 0 0 0 13 8
Must the patient, who is not suitable for organ donation, be declared brain dead before withdrawing LSM?
No, the prospect of a very poor prognosis can be enough 61 0 17 0 78 42 100 80
No, GCS 3 and fixed dilated pupils and no confounders is
enough to stop treatment
13 0 0 50 22 8 0 20
Yes, this is mandatory by law in my country 18 80 17 50 0 50 0 0
Yes, it is not mandatory by law, but I always do that to be sure 7 20 67 0 0 0 0 0
Data presented as percentage
EEG electroencephalography, GCS Glasgow Coma Scale, LSM life-sustaining measures
aAdditional categorical responses, while free text responses were sufficiently similar. This does not mean that the other centers do not follow their
national protocol
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In all centers in the Baltic States (N = 5), nondonor
patients were declared brain dead before withdrawing
LSM. In several centers in Eastern Europe and South-
ern Europe (N = 1, 17% and N = 6, 50%, respectively),
it was mandatory to declare a patient brain dead be-
fore withdrawing LSM in nondonor patients, whereas
in other centers from the same region this was not
mandatory.
Practices around postmortem organ donation
Would you consider organ donation after circulatory arrest
in a patient in whom mechanical ventilation will be
withdrawn, but who is not brain dead?
Organ donation after circulatory arrest was forbidden in
30 (45%) centers (Fig. 1 and Table 3).
In all centers in the UK (N = 8), postmortem organ
donation after circulatory arrest was approved. In centers
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Sample total
(N=66)
Baltic States
(N=5)
Eastern Europe
(N=6)
Israel (N=2) Northern Europe
(N=9)
Southern Europe
(N=12)
United Kingdom
(N=8)
Western Europe
(N=24)
No, this is forbidden in my country No, although it would be permitted, I would not do this Yes, sometimes Yes, always
Fig. 1 Results of question 13 (Questionnaire 8): Would you consider organ donation after circulatory arrest in a patient in whom mechanical
ventilation will be withdrawn, but who is not brain dead?
Table 3 Practices around circulatory arrest organ donation and ventricular drain removal
Region
Answer Sample
total
(N = 66)
Baltic
States
(N = 5)
Eastern
Europe
(N = 6)
Israel
(N =
2)
Northern
Europe
(N = 9)
Southern
Europe
(N = 12)
United
Kingdom
(N = 8)
Western
Europe
(N = 24)
Would you consider organ donation after circulatory arrest in a patient in whom mechanical ventilation will be withdrawn, but who is not brain dead?
No, this is forbidden in my country 45 80 67 50 67 42 0 42
No, although it would be permitted,
I would not do this
15 20 33 0 22 33 0 4
Yes, sometimes 20 0 0 50 11 25 13 29
Yes, always 20 0 0 0 0 0 88 25
Sample
total
(N = 67)
Baltic
States
(N = 5)
Eastern
Europe
(N = 6)
Israel
(N =
2)
Northern
Europe
(N = 9)
Southern
Europe
(N = 12)
United
Kingdom
(N = 8)
Western
Europe
(N = 25)
If the decision is made to withdraw life-sustaining measures, in a patient with high intracranial pressure, but who is not brain dead, would you
remove the ventricular drain (for CSF drainage), but continue other life-sustaining measures in the hope that the patient will become brain dead
and then becomes a suitable candidate for organ donation?
No, never 33 80 33 0 0 17 88 28
Yes, sometimes 51 20 50 100 100 50 13 48
Yes, always 16 0 17 0 0 33 0 24
Data presented as percentage
CSF cerebrospinal fluid
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in the Baltic States, Eastern Europe, and Northern Europe,
organ donation after circulatory arrestwas often forbidden
(N = 4, 80%; N = 4, 67% and N = 6, 67% respectively).
If the decision is made to withdraw life-sustaining measures,
in a patient with high intracranial pressure, but who is not
brain dead, would you remove the ventricular drain (for CSF
drainage), but continue other life-sustaining measures in the
hope that the patient will become brain dead and thereby
becomes a suitable candidate for organ donation?
In 45 (67%) centers, the ventricular drain was sometimes
or always removed. In 11 of these 45 centers (16% of the
Sample total), the ventricular drain was always removed
while continuing other LSM. In 22 (33%) centers, the
ventricular drain was never removed while continuing
other LSM (Fig. 2 and Table 3).
In 4 (80%) centers in the Baltic States and in 7 (88%) cen-
ters in the UK, the ventricular drain was never removed. In
all centers from Israel (N = 2) and Northern Europe (N = 9),
the ventricular drain was “sometimes” removed.
After withdrawal of mechanical ventilation and after
circulatory arrest, when exactly do you declare the patient
dead in case of a circulatory death organ donor, and in
cases not suitable as an organ donor?
In the case of a circulatory death organ donor, it was most
common (N = 15, 23%) to declare the patient dead after
5-min “flatliner-ECG”. In cases not suitable as an organ
donor, it was most common (N = 21, 32%) to declare the
patient dead directly after detection of a “flatliner-ECG”
on the monitor (Table 4).
In all centers in Israel, nondonor patients were de-
clared dead directly after detection of a “flatliner-ECG”
on the monitor. No other region had the same answer in
every center concerning the declaration of death in
donor and nondonor patients.
Discussion
We aimed to investigate specific practices that currently
provoke international discussion in the area of brain
death and postmortem organ donation. We aimed to
quantify and understand potential differences, and pro-
vide impetus for current dialogs toward further
harmonization of practices around brain death and
postmortem organ donation.
Taking all results together, we found agreement on the
clinical evaluation (prerequisites and neurological assess
ment) for brain death determination (BDD) across regions.
In addition to this clinical evaluation, ancillary tests were re-
quired for BDD in 64% of the centers. BDD was deemed
mandatory before withdrawal of life-sustaining measures
(LSM) even outside the context of organ donation in 18%
of the centers. As for practices around postmortem organ
donation across regions, in 67% of the centers a ventricular
drain was sometimes or always removed while other LSM
were continued. Last, in 45% of the centers organ donation
after circulatory arrest was forbidden.
We found important agreement and some differences
regarding practices around brain death. Due to the broad
0%
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Sample total
(N=67)
Baltic States
(N=5)
Eastern Europe
(N=6)
Israel (N=2) Northern Europe
(N=9)
Southern Europe
(N=12)
United Kingdom
(N=8)
Western Europe
(N=25)
No, never Yes, sometimes Yes, always
Fig. 2 Results of question 9 (Questionnaire 8): If the decision is made to withdraw life-sustaining measures, in a patient with high intracranial
pressure, but who is not brain dead, would you remove the ventricular drain (for CSF drainage), but continue other life-sustaining measures in
the hope that the patient will become brain dead and thereby becomes a suitable candidate for organ donation?
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categorical answer possibilities provided, the application
of these findings is limited. First, agreement existed in all
centers on the clinical evaluation for BDD, namely a Glas-
gow Coma Scale (GCS) of three, absence of brain stem re-
flexes, no respiratory efforts in response to an apnea test,
and absence of confounding factors to evaluate conscious-
ness. This is promising, in the light of recent calls to reach
a worldwide consensus on how to determine brain death
[10]. However, in addition to this clinical evaluation, ancil-
lary tests were reported to be required for BDD in two
thirds of centers. These differences in the use of ancillary
tests are in line with previous literature [11–19]. Interest-
ingly, however, there have been calls to abandon ancillary
tests for BDD [20]. In the majority of centers from North-
ern Europe and the United Kingdom (UK), ancillary tests
were not mandatory for BDD. This is in line with the
study by Wahlster et al. [11]. These discrepancies may
suggest differences in ethical principles and regulatory
practice between centers. In some centers it was
mandatory to declare nondonor patients brain dead before
Table 4 Practices around the hands-off time after circulatory arrest
Region
Answer Sample
total
(N = 64)
Baltic
States
(N = 5)
Eastern
Europe
(N = 6)
Israel
(N =
2)
Northern
Europe
(N = 9)
Southern
Europe
(N = 12)
United
Kingdom
(N = 8)
Western
Europe
(N = 22)
After withdrawal of mechanical ventilation and after circulatory arrest, when exactly do you declare the patient dead in case of a circulatory death
organ donor?
Directly after circulatory arrest determined after a
“flatliner-ECG” on the monitor
16 40 0 50 11 8 0 23
After 1-min “flatliner-ECG” indicating circulatory arrest 5 0 0 50 0 8 0 5
After 2-min “flatliner-ECG” 2 0 0 0 0 0 0 5
After 5-min “flatliner-ECG” 23 20 33 0 11 17 50 23
After 10-min “flatliner-ECG” 5 20 17 0 0 0 0 5
After loss of pulsatile arterial curve on the invasive
arterial blood pressure tracing
6 20 17 0 0 0 0 9
After 20-min “flatliner-ECG”a 11 0 0 0 0 58 0 0
Not done in our hospital/countrya 19 0 17 0 78 0 0 18
Other, please specifyb 14 0 17 0 0 8 50 14
Sample
total
(N = 66)
Baltic
States
(N = 5)
Eastern
Europe
(N = 6)
Israel
(N =
2)
Northern
Europe
(N = 9)
Southern
Europe
(N = 12)
United
Kingdom
(N = 8)
Western
Europe
(N = 24)
After withdrawal of mechanical ventilation and after circulatory arrest, after how many minutes circulatory arrest do you declare the patient dead in
cases not suitable as organ donor?
Directly after circulatory arrest determined after a
“flatliner-ECG” on the monitor
32 40 17 100 11 17 13 50
After 1-min “flatliner-ECG” indicating circulatory arrest 5 0 0 0 0 0 0 13
After 2-min “flatliner-ECG” 0 0 0 0 0 0 0 0
After 5-min “flatliner-ECG” 23 20 17 0 22 25 38 21
After 10-min “flatliner-ECG” 6 20 33 0 0 0 0
After loss of pulsatile arterial curve on the invasive
arterial blood pressure tracing
6 20 33 0 11 0 0 0
After 20-min “flatliner-ECG”a 9 0 0 0 0 50 0 0
Not done in our hospital/countrya 8 0 0 0 33 0 0 8
Other, please specifyc 12 0 0 0 22 0 50 8
Data presented as percentage
EEG electroencephalography
aAdditional categorical responses, while free text responses were sufficiently similar
bSpecifications filled in under “other”: “two minutes after loss of pulsatile arterial curve on the invasive arterial blood pressure tracing”; “after 3 min”; “No carotid
pulses and apnoea”; “absence central pulse for 5 mins confirmed by observation for further 5 mins”; “National guidance 5 mins mechanical asystole”; “apnea test
positivity”; “according to the Dutch law on organ donation”; “Protokollbogen zur Feststellung des irreversiblen Hirnfunktionsausfalls”; “at the beginning of the
commission observation (6 h before)”
cSpecifications filled in under “other”: “Control 10 min later”; “After clinical death diagnosis: listen to heart sound, examination of pupils”; “At decision of the
physician”; “No carotid pulses and apnoea”; “absence central pulse for 5 mins confirmed by observation for further 5 mins”; “apnea test positivity”; “according to
the Dutch law on organ donation”; “Protokollbogen zur Feststellung des irreversiblen Hirnfunktionsausfalls”; “at the beginning of the commission observation
(6 h before)”
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withdrawing life-sustaining measures (LSM). Withdrawal
of LSM and the declaration of brain death are two differ-
ent processes. The obligation of BDD before limiting
treatment is debatable, since many non-brain dead pa-
tients may have a hopeless prognosis rendering further
treatment futile.
We also found differences regarding practices around
postmortem organ donation. First, we found differences
concerning the removal of the ventricular drain. Our
questionnaire did not assess in-depth the reasons why
some centers opted to discontinue drainage and remove
the ventricular drain as compared to maintaining the de-
vice in place, and how such continued intervention was
incorporated into the care plan. Second, we found differ-
ences with regard to the possibility for organ donation
after circulatory arrest. These results are in line with
previous literature [21, 22]. The ventricular drain (men-
tioned earlier in this paragraph) seemed to be removed
more often in centers where donation after circulatory
arrest was not possible. If this turns out to be general
practice, this might indicate the need for reevaluation of
organ donation after circulatory arrest in order to pre-
vent future burdensome care. For international figures
on donation and transplantation, we refer the reader to
the Newsletter Transplant 2017 produced by the Council
of Europe of the European Committee [23]. There are
no specific figures available for the centers involved in
the Collaborative European NeuroTrauma Effectiveness
Research in Traumatic Brain Injury (CENTER-TBI)
study. Although the CENTER-TBI study includes im-
portant neurotrauma centers, we do not know to what
extent these centers are responsible for the investigated
figures of the Council of Europe. For the countries
involved in our study, the number of donations after
brain death in 2016 varied between 1.3 per million in-
habitants (Bosnia and Herzegovina) and 33.1 per million
inhabitants (Spain) [23]. Third, we found differences in
hands-off times needed after circulatory arrest in order
to declare a patient dead. This could indicate a lack of
clear evidence on the exact time needed to be sure the
brain has irreversibly lost its function.
Some of the differences appear region specific, but for
other aspects we found variation between centers within
a single region. Differences were even noted between re-
gions participating in Eurotransplant, an organization
that aims to optimally distribute organs by transplanting
across national borders, when no matching recipient is
available on the waiting list in the donor’s country.
Eurotransplant covers part of Europe, and includes eight
countries: Austria, Belgium, Croatia, Germany, Hungary,
the Netherlands, Luxembourg, and Slovenia. The differ-
ences found pertained to all topics covered in this study.
Present-day medicine is said to be affected by the
cultural climate of the society in which it exists [24].
This may indicate that differences in culture could
explain some of the observed variation. Other results,
such as possibilities for organ donation after circulatory
arrest, suggest that variations have a more legal or regu-
latory basis. Observed within-region differences which
suggest a more legal or regulatory basis raise questions
regarding the level of enforcement of pertinent laws, and
may indicate a lack of knowledge, regulatory implemen-
tation, or ambiguous legislation.
This study has several limitations that should be con-
sidered when interpreting the results. First, the partici-
pating neurotrauma centers represent a select group.
The data obtained may therefore not be representative
for all neurotrauma centers within the geographical
areas studied. Second, our sample size made it difficult
to apply more advanced statistics, such as a chi-square
test, cluster analysis, and multidimensional scaling.
Third, the results are based on the perceptions of prac-
tices reported by specific investigators rather than on
clinical data. The CENTER-TBI study will further clarify
actual practices around brain death and postmortem
organ donation by analyzing clinical data. Fourth, inves-
tigators may have interpreted some questions incorrectly
because a questionnaire does not always permit the
nuances appropriate for clinical practice. In clinical
practice, potential alternative options are both more
numerous and complex than can be captured by a
questionnaire. Last, investigators may have presented
(even unwittingly) a more favorable image or presented
individual preferences instead of the general policy in a
center that we asked for.
Future research should focus on extending this study
to a larger group of neurotrauma centers across the
world in order to examine (in more advanced statistics)
whether our results also apply to other centers. Further-
more, it would be interesting to study the origin of the
differences found (e.g., cultural differences and differences
pertaining to legislation). The complexity of some of the
drivers of reported practice makes the case for mixed
methods approaches to this problem, with a potentially
substantive role for qualitative research methods. These
strategies are important in order to inform preferred ap-
proaches to improve harmonization in neurotrauma cen-
ters across Europe and Israel.
Most importantly, current dialogs should be continued,
and we hope that our findings may provide a basis toward
further harmonization of practices around brain death
and postmortem organ donation.
Conclusion
This study showed both agreement and some regional
differences regarding practices around brain death and
postmortem organ donation. We hope our results help
quantify and understand potential differences, and
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provide impetus for current dialogs toward further
harmonization of practices around brain death and post-
mortem organ donation.
Additional file
Additional file 1: Provider profiling questionnaires used for this study
(Questionnaires 1, 7, and 8). (PDF 596 kb)
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